Citation 13651

MARTIN NIZARD,F: SAHPAZ,S: FURMAN,C: FRUCHART,JC: DURIEZ,P: BAILLEUL,F:. (2003). NATURAL PHENYLPROPANOIDS PROTECT ENDOTHELIAL CELLS AGAINST OXIDIZED LDL-INDUCED CYTOTOXICITY.. 69(3)

Citation Details

Title	NATURAL PHENYLPROPANOIDS PROTECT ENDOTHELIAL CELLS AGAINST OXIDIZED LDL-INDUCED CYTOTOXICITY.
Authors	MARTIN NIZARD,F: SAHPAZ,S: FURMAN,C: FRUCHART,JC: DURIEZ,P: BAILLEUL,F:
Year	2003
Volume	69
Issue	3

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	PLATELET ACTIVATING FACTOR ACETYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERBASCOSIDE	ACTIVE
2	PLATELET ACTIVATING FACTOR ACETYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERBASCOSIDE	ACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERBASCOSIDE	ACTIVE
4	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERBASCOSIDE	ACTIVE
5	CYTOTOXICITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERBASCOSIDE	ACTIVE
6	PLATELET ACTIVATING FACTOR ACETYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORSYTHOSIDE B	ACTIVE
7	PLATELET ACTIVATING FACTOR ACETYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORSYTHOSIDE B	ACTIVE
8	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORSYTHOSIDE B	ACTIVE
9	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORSYTHOSIDE B	ACTIVE
10	CYTOTOXICITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORSYTHOSIDE B	ACTIVE
11	PLATELET ACTIVATING FACTOR ACETYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARENARIOSIDE	ACTIVE
12	PLATELET ACTIVATING FACTOR ACETYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARENARIOSIDE	ACTIVE
13	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARENARIOSIDE	ACTIVE
14	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARENARIOSIDE	ACTIVE
15	CYTOTOXICITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARENARIOSIDE	ACTIVE
16	PLATELET ACTIVATING FACTOR ACETYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BALLOTETROSIDE	ACTIVE
17	PLATELET ACTIVATING FACTOR ACETYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BALLOTETROSIDE	ACTIVE
18	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BALLOTETROSIDE	ACTIVE
19	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BALLOTETROSIDE	ACTIVE
20	CYTOTOXICITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BALLOTETROSIDE	ACTIVE
21	PLATELET ACTIVATING FACTOR ACETYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MALIC ACID,1-O-CAFFEOYL:	ACTIVE
22	PLATELET ACTIVATING FACTOR ACETYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MALIC ACID,1-O-CAFFEOYL:	ACTIVE
23	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MALIC ACID,1-O-CAFFEOYL:	ACTIVE
24	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MALIC ACID,1-O-CAFFEOYL:	ACTIVE
25	CYTOTOXICITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MALIC ACID,1-O-CAFFEOYL:	ACTIVE

Citation 13651

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1